Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5204374
Max Phase: Preclinical
Molecular Formula: C28H29F6N3O
Molecular Weight: 537.55
Associated Items:
ID: ALA5204374
Max Phase: Preclinical
Molecular Formula: C28H29F6N3O
Molecular Weight: 537.55
Associated Items:
Canonical SMILES: CN1C=C2C[C@@H]3[C@H](C[C@@H](CNC(=O)/C=C/c4ccc(C(F)(F)F)cc4C(F)(F)F)CN3C)C3C=CC=C1C23
Standard InChI: InChI=1S/C28H29F6N3O/c1-36-14-16(10-21-20-4-3-5-23-26(20)18(11-24(21)36)15-37(23)2)13-35-25(38)9-7-17-6-8-19(27(29,30)31)12-22(17)28(32,33)34/h3-9,12,15-16,20-21,24,26H,10-11,13-14H2,1-2H3,(H,35,38)/b9-7+/t16-,20?,21+,24+,26?/m0/s1
Standard InChI Key: KDBRDFZFZAXAMN-WLNDMZQWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 537.55 | Molecular Weight (Monoisotopic): 537.2215 | AlogP: 5.71 | #Rotatable Bonds: 4 |
Polar Surface Area: 35.58 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 10.12 | CX LogP: 4.16 | CX LogD: 0.93 |
Aromatic Rings: 1 | Heavy Atoms: 38 | QED Weighted: 0.40 | Np Likeness Score: 0.30 |
1. Johnson JW, Ellis MJ, Piquette ZA, MacNair C, Carfrae L, Bhando T, Ritchie NE, Saliba P, Brown ED, Magolan J.. (2022) Antibacterial Activity of Metergoline Analogues: Revisiting the Ergot Alkaloid Scaffold for Antibiotic Discovery., 13 (2.0): [PMID:35178184] [10.1021/acsmedchemlett.1c00648] |
Source(1):